Discovery of Novel 2-Aryl-4-benzoyl-imidazoles Targeting the Colchicines Binding Site in Tubulin As Potential Anticancer Agents
- 4 October 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 53 (20), 7414-7427
- https://doi.org/10.1021/jm100884b
Abstract
A series of 2-aryl-4-benzoyl-imidazoles (ABI) was synthesized as a result of structural modifications based on the previous set of 2-aryl-imidazole-4-carboxylic amide (AICA) derivatives and 4-substituted methoxylbenzoyl-aryl-thiazoles (SMART). The average IC50 of the most active compound (5da) was 15.7 nM. ABI analogues have substantially improved aqueous solubility (48.9 μg/mL for 5ga vs 0.909 μg/mL for SMART-1, 0.137 μg/mL for paclitaxel, and 1.04 μg/mL for combretastatin A4). Mechanism of action studies indicate that the anticancer activity of ABI analogues is through inhibition of tubulin polymerization by interacting with the colchicine binding site. Unlike paclitaxel and colchicine, the ABI compounds were equally potent against multidrug resistant cancer cells and the sensitive parental melanoma cancer cells. In vivo results indicated that 5cb was more effective than DTIC in inhibiting melanoma xenograph tumor growth. Our results suggest that the novel ABI compounds may be developed to effectively treat drug-resistant tumors.Keywords
This publication has 32 references indexed in Scilit:
- A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancerBritish Journal of Cancer, 2010
- Variations in the colchicine-binding domain provide insight into the structural switch of tubulinProceedings of the National Academy of Sciences of the United States of America, 2009
- Doxorubicin and Paclitaxel-Loaded Lipid-Based Nanoparticles Overcome Multidrug Resistance by Inhibiting P-Glycoprotein and Depleting ATPCancer Research, 2009
- Discovery of 4-Substituted Methoxybenzoyl-aryl-thiazole as Novel Anticancer Agents: Synthesis, Biological Evaluation, and Structure−Activity RelationshipsJournal of Medicinal Chemistry, 2009
- Identification of a Small Molecule with Synthetic Lethality for K-Ras and Protein Kinase C IotaCancer Research, 2008
- Synthesis and antiproliferative activity of imidazole and imidazoline analogs for melanomaBioorganic & Medicinal Chemistry Letters, 2008
- Synthesis of Naturally Occurring Pyrazine and Imidazole Alkaloids from Botryllus LeachiRID=?a?ID=?a? Dedicated to Prof. G . Märkl on the occasion of his 75 th birthdayMonatshefte für Chemie / Chemical Monthly, 2004
- Systematic variation in gene expression patterns in human cancer cell linesNature Genetics, 2000
- Dehydrogenation of Imidazolines to Imidazoles with Pd-CarbonSynthetic Communications, 1990
- On the Origin of Cancer CellsScience, 1956